Key result
Accelerated biological aging linked to ~4% higher intraoperative hypotension risk per SD.
Why the study?
Identifying patients at high risk for intraoperative hypotension remains challenging, and accelerated biological aging may increase susceptibility to hypotensive events but remains underutilized in perioperative medicine.
Does accelerated biological aging increase the risk and severity of intraoperative hypotension in adults undergoing major surgery?
Cohort (n=116,996)
Yes
Does accelerated biological aging increase the risk and severity of intraoperative hypotension in adults undergoing major surgery?
Accelerated biological aging, assessed via the Phenotypic Age Acceleration index, is independently associated with an increased risk and severity of intraoperative hypotension during major surgery, supporting its utility in preoperative risk stratification.
Answers are grounded in this paper and cite their sources.
May inform preoperative hypotension risk assessment; leaves open whether PhenoAgeAccel-guided interventions improve outcomes.
BACKGROUND: Intraoperative hypotension (IOH) is a prevalent hemodynamic complication associated with adverse postoperative outcomes. Identifying patients at high risk for IOH remains a challenge. Accelerated biological aging, reflecting cumulative physiological decline, may heighten susceptibility to hypotensive events by impairing cardiovascular homeostasis and autonomic regulation, making it a potent yet underutilized predictor in perioperative medicine. MATERIALS AND METHODS: This multicenter retrospective cohort study analyzed 116,996 adults undergoing major cardiac and non-cardiac surgery across three tertiary academic medical centers in Eastern China. Accelerated biological aging was measured using Phenotypic Age Acceleration (PhenoAgeAccel). Outcomes included incidence of IOH (Mean arterial pressure (MAP) < 60 mmHg), cumulative duration, and area under curve (AUC) below this threshold. AUC was calculated using the trapezoidal integration method to quantify the integrated area where MAP < 60 mmHg. Associations were assessed using generalized linear regression, adjusting for key confounders. Accelerated biological aging also correlated with prolonged IOH duration and increased AUC. Subgroup analyses suggested increased IOH susceptibility associated with accelerated biological aging across most subgroups except patients of 40-79 years and those underwent cardiac surgery. Several estimates had wide confidence intervals, indicating variability and uncertainty in the subgroup-specific effects. CONCLUSIONS: Accelerated biological aging was significantly associated with both increased risk and greater severity of intraoperative hypotension. These findings support the integration of biological aging metrics, such as PhenoAgeAccel, into preoperative risk assessment to optimize hemodynamic management in vulnerable surgical populations.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2025) conducted a cohort in Major cardiac and non-cardiac surgery (n=116,996). Accelerated biological aging (PhenoAgeAccel) vs. Expected or decelerated biological aging (PhenoAgeAccel ≤ 0 SD) was evaluated on Incidence of intraoperative hypotension (MAP < 60 mmHg) (aOR 1.04, 95% CI 1.02-1.06, p=<0.001). Accelerated biological aging was associated with an increased risk of intraoperative hypotension.
Synapse has enriched 10 related papers. Consider them for comparative context: